McCoy J Philip
Flow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, 10 Center Drive, MSC 1357, Building 10, Room 4A07, Bethesda, MD 20892, USA.
Hematol Oncol Clin North Am. 2002 Apr;16(2):229-43. doi: 10.1016/s0889-8588(01)00015-6.
Although the basic principles of flow cytometry have changed little in the past quarter century, the applications of this technology have evolved substantially. As in the past, cytometers interrogate individual cells or particles in a stream with a laser as the cells move past a set of stationary detectors. Increasingly, more colors of fluorescence are being detected by cytometers, faster analysis and sorting rates are becoming possible, cytometers capable of multidirectional sorting are being marketed, and more reagents are becoming available for a wide variety of applications. Furthermore, flow cytometry has not stopped evolving. The development of narrow spectrum flourescent probes, the integration of molecular biologic techniques with flow cytometry, and the evaluation of cell-free markers such as cytokines will be key components in the continuing evolution of flow cytometry.
尽管在过去的四分之一世纪里,流式细胞术的基本原理变化不大,但这项技术的应用却有了显著发展。和过去一样,细胞仪在细胞流经一组固定探测器时,用激光对液流中的单个细胞或颗粒进行检测。越来越多的细胞仪能够检测更多颜色的荧光,分析和分选速度越来越快,能够进行多向分选的细胞仪已投放市场,并且有更多试剂可用于各种各样的应用。此外,流式细胞术仍在不断发展。窄谱荧光探针的开发、分子生物学技术与流式细胞术的整合,以及对细胞因子等无细胞标志物的评估,将是流式细胞术持续发展的关键组成部分。